These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 8013642

  • 1. Application of 13C NMR spectroscopy to paratope mapping for larger antigen-Fab complexes.
    Kim H, Kato K, Yamato S, Igarashi T, Matsunaga C, Ohtsuka H, Higuchi A, Nomura N, Noguchi H, Arata Y.
    FEBS Lett; 1994 Jun 13; 346(2-3):246-50. PubMed ID: 8013642
    [Abstract] [Full Text] [Related]

  • 2. Design of interchain disulfide bonds in the framework region of the Fv fragment of the monoclonal antibody B3.
    Jung SH, Pastan I, Lee B.
    Proteins; 1994 May 13; 19(1):35-47. PubMed ID: 8066084
    [Abstract] [Full Text] [Related]

  • 3. Rapid humanization of the Fv of monoclonal antibody B3 by using framework exchange of the recombinant immunotoxin B3(Fv)-PE38.
    Benhar I, Padlan EA, Jung SH, Lee B, Pastan I.
    Proc Natl Acad Sci U S A; 1994 Dec 06; 91(25):12051-5. PubMed ID: 7991583
    [Abstract] [Full Text] [Related]

  • 4. Engineering interchain disulfide bonds into conserved framework regions of Fv fragments: improved biochemical characteristics of recombinant immunotoxins containing disulfide-stabilized Fv.
    Reiter Y, Brinkmann U, Webber KO, Jung SH, Lee B, Pastan I.
    Protein Eng; 1994 May 06; 7(5):697-704. PubMed ID: 8073039
    [Abstract] [Full Text] [Related]

  • 5. Stabilization of the Fv fragments in recombinant immunotoxins by disulfide bonds engineered into conserved framework regions.
    Reiter Y, Brinkmann U, Kreitman RJ, Jung SH, Lee B, Pastan I.
    Biochemistry; 1994 May 10; 33(18):5451-9. PubMed ID: 7910034
    [Abstract] [Full Text] [Related]

  • 6. Role of the domain-domain interaction in the construction of the antigen combining site. A comparative study by 1H-15N shift correlation NMR spectroscopy of the Fv and Fab fragments of anti-dansyl mouse monoclonal antibody.
    Takahashi H, Tamura H, Shimba N, Shimada I, Arata Y.
    J Mol Biol; 1994 Oct 28; 243(3):494-503. PubMed ID: 7966275
    [Abstract] [Full Text] [Related]

  • 7. Three-dimensional structures of the free and antigen-bound Fab from monoclonal antilysozyme antibody HyHEL-63(,).
    Li Y, Li H, Smith-Gill SJ, Mariuzza RA.
    Biochemistry; 2000 May 30; 39(21):6296-309. PubMed ID: 10828942
    [Abstract] [Full Text] [Related]

  • 8. B3(Fab)-PE38M: a recombinant immunotoxin in which a mutant form of Pseudomonas exotoxin is fused to the Fab fragment of monoclonal antibody B3.
    Choe M, Webber KO, Pastan I.
    Cancer Res; 1994 Jul 01; 54(13):3460-7. PubMed ID: 8012967
    [Abstract] [Full Text] [Related]

  • 9. Functional mapping of conserved residues located at the VL and VH domain interface of a Fab.
    Chatellier J, Van Regenmortel MH, Vernet T, Altschuh D.
    J Mol Biol; 1996 Nov 22; 264(1):1-6. PubMed ID: 8950262
    [Abstract] [Full Text] [Related]

  • 10. Biochemical and immunochemical studies of proteolytic fragments of exotoxin A from Pseudomonas aeruginosa.
    Bourdenet S, Vacheron MJ, Guinand M, Michel G, Arminjon F.
    Eur J Biochem; 1990 Sep 11; 192(2):379-85. PubMed ID: 2170123
    [Abstract] [Full Text] [Related]

  • 11. Improved binding and antitumor activity of a recombinant anti-erbB2 immunotoxin by disulfide stabilization of the Fv fragment.
    Reiter Y, Brinkmann U, Jung SH, Lee B, Kasprzyk PG, King CR, Pastan I.
    J Biol Chem; 1994 Jul 15; 269(28):18327-31. PubMed ID: 7913461
    [Abstract] [Full Text] [Related]

  • 12. Structural and dynamic properties of the Fv fragment and the single-chain Fv fragment of an antibody in solution investigated by heteronuclear three-dimensional NMR spectroscopy.
    Freund C, Ross A, Plückthun A, Holak TA.
    Biochemistry; 1994 Mar 22; 33(11):3296-303. PubMed ID: 8136365
    [Abstract] [Full Text] [Related]

  • 13. A comparative analysis of the immunological evolution of antibody 28B4.
    Yin J, Mundorff EC, Yang PL, Wendt KU, Hanway D, Stevens RC, Schultz PG.
    Biochemistry; 2001 Sep 11; 40(36):10764-73. PubMed ID: 11535051
    [Abstract] [Full Text] [Related]

  • 14. Diphtheria toxin and Pseudomonas aeruginosa exotoxin A: active-site structure and enzymic mechanism.
    Wilson BA, Collier RJ.
    Curr Top Microbiol Immunol; 1992 Sep 11; 175():27-41. PubMed ID: 1628498
    [No Abstract] [Full Text] [Related]

  • 15. Carbon-13 NMR study of switch variant anti-dansyl antibodies: antigen binding and domain-domain interactions.
    Kato K, Matsunaga C, Odaka A, Yamato S, Takaha W, Shimada I, Arata Y.
    Biochemistry; 1991 Jul 02; 30(26):6604-10. PubMed ID: 2054358
    [Abstract] [Full Text] [Related]

  • 16. Recombinant immunotoxins containing the VH or VL domain of monoclonal antibody B3 fused to Pseudomonas exotoxin.
    Brinkmann U, Lee BK, Pastan I.
    J Immunol; 1993 Apr 01; 150(7):2774-82. PubMed ID: 8454854
    [Abstract] [Full Text] [Related]

  • 17. A recombinant immunotoxin that is active on prostate cancer cells and that is composed of the Fv region of monoclonal antibody PR1 and a truncated form of Pseudomonas exotoxin.
    Brinkmann U, Gallo M, Brinkmann E, Kunwar S, Pastan I.
    Proc Natl Acad Sci U S A; 1993 Jan 15; 90(2):547-51. PubMed ID: 8421689
    [Abstract] [Full Text] [Related]

  • 18. Identification of residues that stabilize the single-chain Fv of monoclonal antibodies B3.
    Benhar I, Pastan I.
    J Biol Chem; 1995 Oct 06; 270(40):23373-80. PubMed ID: 7559495
    [Abstract] [Full Text] [Related]

  • 19. A recombinant immunotoxin containing a disulfide-stabilized Fv fragment.
    Brinkmann U, Reiter Y, Jung SH, Lee B, Pastan I.
    Proc Natl Acad Sci U S A; 1993 Aug 15; 90(16):7538-42. PubMed ID: 8356052
    [Abstract] [Full Text] [Related]

  • 20. The structure of Pseudomonas exotoxin A as a guide to rational design.
    Nicholls PJ, Youle RJ.
    Targeted Diagn Ther; 1992 Aug 15; 7():439-46. PubMed ID: 1633305
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.